| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.001 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.002 |